PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to verify efficacy and safety of a bilateral deep brain stimulation (DBS) of the Nucleus accumbens (NAc) as a treatment option for severe opioid addiction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for early_phase_1
Started Dec 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2014
CompletedFirst Posted
Study publicly available on registry
November 4, 2014
CompletedStudy Start
First participant enrolled
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedOctober 14, 2016
August 1, 2016
1.8 years
September 26, 2014
October 13, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Schedule for the Assessment of Negative Symptoms (SANS)
6 month
Secondary Outcomes (3)
Chronic Hunger Scale
6 month
Beck Depression Inventory
6 month
Buss & Perry Aggression Questionnaire
6 month
Study Arms (2)
Deep Brain Stimulation
ACTIVE COMPARATORStimulator is ON
Placebo
SHAM COMPARATORStimulator is OFF
Interventions
Eligibility Criteria
You may qualify if:
- Age \> 18 years old.
- In accordance with the diagnostic standards of DSM-IV \& ICD-10 for addicted and DSM-IV for abstinence.
- Qualitative urine detection for opioids showing positive result.
- Cleared for 8 to 36 hours after their last drug taking.
- Fully understood and signed on informed consent.
You may not qualify if:
- Person with consciousness disorder on opioid abstinence, seriously aggressive, heavily dehydrated and intending to commit suicide.
- Patients with serious liver and kidney dysfunction, pulmonary decompensation, or complicated with serious damage in other systems.
- Patients with serious infectious disease.
- Patients with history of serious neurological or psychiatrical diseases.
- Person with history of HIV infection or serious malnutrition.
- Dependent upon and addicted to multiple drugs.
- Attended some other drug trials within one month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Pins Medical Co., Ltdlead
- Beijing Tiantan Hospitalcollaborator
Study Sites (1)
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, 310000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Li Luming, PhD
Tsinghua University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2014
First Posted
November 4, 2014
Study Start
December 1, 2016
Primary Completion
September 1, 2018
Study Completion
December 1, 2018
Last Updated
October 14, 2016
Record last verified: 2016-08